Interferon-gamma Release Tests
"Interferon-gamma Release Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The assay of INTERFERON-GAMMA released from lymphocytes after their exposure to a specific test antigen, to check for IMMUNOLOGIC MEMORY resulting from a previous exposure to the antigen. The amount of interferon-gamma released is usually assayed by an ENZYME-LINKED IMMUNOSORBENT ASSAY.
Descriptor ID |
D059425
|
MeSH Number(s) |
E01.370.225.812.453 E05.200.812.453 E05.478.594.475
|
Concept/Terms |
Interferon-gamma Release Tests- Interferon-gamma Release Tests
- Interferon gamma Release Tests
- Interferon-gamma Release Test
- Release Test, Interferon-gamma
- Release Tests, Interferon-gamma
- Test, Interferon-gamma Release
- Tests, Interferon-gamma Release
- Interferon-gamma Release Assays
- Assay, Interferon-gamma Release
- Assays, Interferon-gamma Release
- Interferon gamma Release Assays
- Interferon-gamma Release Assay
- Release Assay, Interferon-gamma
- Release Assays, Interferon-gamma
|
Below are MeSH descriptors whose meaning is more general than "Interferon-gamma Release Tests".
Below are MeSH descriptors whose meaning is more specific than "Interferon-gamma Release Tests".
This graph shows the total number of publications written about "Interferon-gamma Release Tests" by people in this website by year, and whether "Interferon-gamma Release Tests" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2015 | 0 | 1 | 1 |
2018 | 1 | 1 | 2 |
2020 | 0 | 1 | 1 |
2021 | 1 | 0 | 1 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interferon-gamma Release Tests" by people in Profiles.
-
Magee MJ, Khakharia A, Gandhi NR, Day CL, Kornfeld H, Rhee MK, Phillips LS. Increased Risk of Incident Diabetes Among Individuals With Latent Tuberculosis Infection. Diabetes Care. 2022 04 01; 45(4):880-887.
-
Gibson L. An Interferon-? Release Assay for Evaluation of Cell-mediated Immunity in Infants With Congenital Cytomegalovirus Infection. Clin Infect Dis. 2021 08 02; 73(3):374-375.
-
Daniel VT, Blankenship KC, Daly RF, Tkachenko E, Morss-Walton PC, Levin NA. Low rate of conversion to positive tuberculosis status among patients with psoriasis on biologic therapies: A retrospective study from a US academic medical center. J Am Acad Dermatol. 2021 Mar; 84(3):830-833.
-
Makarenko VV, Al-Turkmani MR, Rao LV. Clinical variables associated with indeterminate QuantiFERON?-TB Gold assay results: role of pre-incubation delay. Int J Tuberc Lung Dis. 2018 12 01; 22(12):1429-1434.
-
Liu X, Hou XF, Gao L, Deng GF, Zhang MX, Deng QY, Ye TS, Yang QT, Zhou BP, Wen ZH, Liu HY, Kornfeld H, Chen XC. Indicators for prediction of Mycobacterium tuberculosis positivity detected with bronchoalveolar lavage fluid. Infect Dis Poverty. 2018 Mar 24; 7(1):22.
-
Yang Q, Xu Q, Chen Q, Li J, Zhang M, Cai Y, Liu H, Zhou Y, Deng G, Deng Q, Zhou B, Kornfeld H, Chen X. Discriminating Active Tuberculosis from Latent Tuberculosis Infection by flow cytometric measurement of CD161-expressing T cells. Sci Rep. 2015 Dec 08; 5:17918.
-
Wong SH, Ip M, Tang W, Lin Z, Kee C, Hung E, Lui G, Lee N, Chan FK, Wu JC, Sung JJ, Ng SC. Performance of interferon-gamma release assay for tuberculosis screening in inflammatory bowel disease patients. Inflamm Bowel Dis. 2014 Nov; 20(11):2067-72.